These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
411 related items for PubMed ID: 12411042
21. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Moseley AB, Bacigalupo A. Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [Abstract] [Full Text] [Related]
22. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors. Finke J, Brugger W, Bertz H, Behringer D, Kunzmann R, Weber-Nordt RM, Kanz L, Mertelsmann R. Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376 [Abstract] [Full Text] [Related]
23. Allogeneic peripheral blood stem cell transplantation in patients with haematological malignancies. Shamsi TS, Irfan M, Ansari SH, Farzana T, Khalid MZ, Panjwani VK, Baig MI, Shakoor N. J Coll Physicians Surg Pak; 2004 Sep; 14(9):522-6. PubMed ID: 15353134 [Abstract] [Full Text] [Related]
24. Allogeneic transplantation of peripheral blood progenitor cells in children: experience of two pediatric centers. Miniero R, Busca A, Bonetti F, Giorgiani G, Zecca M, Berger M, Incarbone E, Vassallo E, Perotti C, Locatelli F. Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S33-6. PubMed ID: 9989887 [Abstract] [Full Text] [Related]
25. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group. Urbano-Ispizua A, Solano C, Brunet S, Hernández F, Sanz G, Alegre A, Petit J, Besalduch J, Vivancos P, Díaz MA, Moraleda JM, Carreras E, Ojeda E, de la Rubia J, Benet I, Domingo-Albós A, García-Conde J, Rozman C. Bone Marrow Transplant; 1996 Jul; 18(1):35-40. PubMed ID: 8831993 [Abstract] [Full Text] [Related]
26. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, Felicini R, Falcinelli F, Velardi A, Ruggeri L, Aloisi T, Saab JP, Santucci A, Perruccio K, Martelli MP, Mecucci C, Reisner Y, Martelli MF. J Clin Oncol; 2005 May 20; 23(15):3447-54. PubMed ID: 15753458 [Abstract] [Full Text] [Related]
27. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation]. Lin Q, Dong M, Wang QM, Wen JY, Wu XY. Ai Zheng; 2006 Oct 20; 25(10):1261-5. PubMed ID: 17059772 [Abstract] [Full Text] [Related]
28. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY. Biol Blood Marrow Transplant; 2009 Feb 20; 15(2):266-73. PubMed ID: 19167687 [Abstract] [Full Text] [Related]
29. Allogeneic peripheral blood stem cell transplantations in children--a single center experience. Sufliarska S, Horáková J, Bodová I, Martinka J, Hrubisko M, Kovács L, Jancovicová K, Lukác J. Neoplasma; 2004 Feb 20; 51(2):110-6. PubMed ID: 15190420 [Abstract] [Full Text] [Related]
30. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias. Carella AM, Lerma E, Dejana A, Corsetti MT, Celesti L, Bruni R, Benvenuto F, Figari O, Parodi C, Carlier P, Florio G, Lercari G, Valbonesi M, Casarino L, De Stefano F, Geniram A, Venturino M, Tedeschi L, Palmieri G, Piaggio G, Podestà M, Frassoni F, Van Lint MT, Marmont AM, Bacigalupo A. Haematologica; 1998 Oct 20; 83(10):904-9. PubMed ID: 9830799 [Abstract] [Full Text] [Related]
31. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT. Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, Ojeda E, Bargay J, Moraleda JM, Bailen A, Sierra J, García-Conde J, Rozman C. Bone Marrow Transplant; 1998 Dec 20; 22(12):1129-35. PubMed ID: 9894714 [Abstract] [Full Text] [Related]
32. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia. Vicent MG, Madero L, Ortega JJ, Martinez A, Gomez P, Verdeguer A, Badell I, Muñoz A, Olive T, Maldonado MS, Bureo E, Cubells J, Diaz MA, Spanish Working Party for BMT in Children (GETMON). Bone Marrow Transplant; 2002 Jul 20; 30(1):9-13. PubMed ID: 12105771 [Abstract] [Full Text] [Related]
33. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia]. Wang Y, Liu KY, Xu LP, Liu DH, Chen H, Han W, Chen YH, Shi HX, Zhang YC, Wang JZ, Zhang XU, Chen Y, Huang XJ, Lu DP. Zhonghua Nei Ke Za Zhi; 2007 Nov 20; 46(11):903-6. PubMed ID: 18261271 [Abstract] [Full Text] [Related]
34. [Unrelated cord blood transplantation for the treatment of hematological malignancies]. Ren HY, Zhang YC, Huang XJ, Xu LP, Liu KY, Li D, Guo NL, Lu DP. Zhonghua Xue Ye Xue Za Zhi; 2003 Feb 20; 24(2):82-5. PubMed ID: 12697102 [Abstract] [Full Text] [Related]
35. [Preliminary study of HLA haplotype matched and T-cell undepleted allogeneic bone marrow transplantation for treatment of leukemia]. Ji S, Chen H, Wang H. Zhonghua Xue Ye Xue Za Zhi; 2001 Aug 20; 22(8):408-10. PubMed ID: 11718090 [Abstract] [Full Text] [Related]
36. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation]. Sawada H, Wake A, Yamasaki Y, Izumi Y. Rinsho Ketsueki; 2000 Jun 20; 41(6):500-6. PubMed ID: 10921350 [Abstract] [Full Text] [Related]
37. Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation. Ferrá C, Rodríguez-Luaces M, Gallardo D, Encuentra M, Martín-Henao GA, Peris J, Ancín I, Sarrá J, Berlanga JJ, García J, Grañena A. Bone Marrow Transplant; 2001 Nov 20; 28(10):963-8. PubMed ID: 11753552 [Abstract] [Full Text] [Related]
38. Allogeneic peripheral blood stem cell transplantation in 23 adult patients with hematologic malignancies: a single-center experience. Takenaka K, Shinagawa K, Sunami K, Fujii N, Hiramatsu Y, Maeda Y, Nawa Y, Katayama Y, Teshima T, Ishimaru F, Kiura K, Ikeda K, Harada M. Int J Hematol; 2000 Oct 20; 72(3):362-70. PubMed ID: 11185996 [Abstract] [Full Text] [Related]
39. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft. di Grazia C, Raiola AM, Van Lint MT, Lamparelli T, Gualandi F, Berisso G, Bregante S, Dominietto A, Mordini N, Bruno B, Frassoni F, Bacigalupo A. Haematologica; 2001 Jun 20; 86(6):646-51. PubMed ID: 11418375 [Abstract] [Full Text] [Related]
40. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L. Ann Med; 2008 Jun 20; 40(6):444-55. PubMed ID: 18608121 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]